Juvederm Volux and Voluma at Korean Clinics: When to Pay Imported Premium

The Allergan fillers Western patients often request specifically

International patients arriving at Korean clinics for filler treatment often arrive with specific brand requests — typically asking for Juvederm products they\'re familiar with from home country marketing. Korean clinics stock these imported Allergan fillers alongside local Korean alternatives, but at significantly higher cost. The question for international patients: when does paying the imported premium make sense, and when do Korean alternatives deliver equivalent results?

Understanding the specific advantages of Volux XC and Voluma helps make informed decisions. For certain applications — chin and jawline definition specifically — Volux\'s unique formulation characteristics justify premium pricing. For other applications, Korean alternatives offer comparable performance.

What makes Volux XC distinctive

The technical specifications

  • Hyaluronic acid filler from Allergan
  • FDA-approved for jawline and chin (2022)
  • Higher G\' (gel firmness) than other Juvederm products
  • Twice the lifting capacity of Voluma
  • Three times the cohesivity of standard HA fillers
  • Mimics bone-like material structure

Why this matters for chin/jawline

  • Bone-like cohesivity supports projection
  • Maintains shape against gravity
  • Resists deformation under skin pressure
  • Better long-term stability than softer fillers
  • More precise sculpting capability

Specific advantages over Korean alternatives

  • Stronger lift
  • Better cohesivity for sharp definition
  • Longer duration in lifting
  • Specifically engineered for skeletal contour

What makes Voluma distinctive

The technical specifications

  • Hyaluronic acid filler from Allergan
  • FDA-approved for cheek augmentation (2013)
  • Also approved for chin augmentation
  • Vycross technology for stability
  • Results last 12–24 months
  • High cohesivity for lifting

Why this matters for cheeks

  • Strong lift capability
  • Natural-feeling movement
  • Long-lasting volume restoration
  • Excellent for mid-face augmentation
  • Established clinical track record

Korean filler alternatives

For chin/jawline applications

Yvoire Volume (Korean premium)

  • High cohesivity Korean filler
  • Good lifting capacity
  • Established Korean brand
  • 50% of Volux cost
  • Comparable but not identical performance

Chaeum Premium (Korean specialty)

  • Korean filler with lifting focus
  • Mid-tier premium positioning
  • Less established than Volux but comparable

Restylane SubQ

  • European Galderma product
  • Heavier filler for deep placement
  • Alternative to Volux at similar cost

For cheek applications

Yvoire Volume

  • Suitable for cheek augmentation
  • Korean clinic standard
  • Half the cost of Voluma

Restylane Volyme

  • European alternative
  • Comparable performance to Voluma
  • Available in Korean clinics

Neuramis Volume

  • Korean filler option
  • Mid-tier pricing
  • Adequate for many cheek applications

Cost comparison in Korea (2026)

Volux XC per syringe

  • Imported Allergan Volux: ₩900,000–1,400,000 ($680–1,050)
  • Premium Gangnam clinic: ₩1,200,000–1,800,000
  • Specialty applications justify cost

Voluma per syringe

  • Imported Allergan Voluma: ₩800,000–1,200,000 ($600–900)
  • Premium Gangnam clinic: ₩1,000,000–1,500,000

Korean alternative comparison

  • Yvoire Volume: ₩400,000–550,000 ($300–415)
  • Chaeum Premium: ₩400,000–600,000
  • Neuramis Volume: ₩300,000–450,000

The cost calculation

  • Imported = 2–3x Korean alternative cost
  • Multi-syringe procedures: significant cost difference
  • Long-term: imports may last slightly longer
  • Choose based on specific application priority

When to pay imported premium

Best applications for Volux

  • Significant chin projection enhancement
  • Sharp jawline definition
  • Pre-event maximum lifting
  • Patients who tried Korean alternatives unsatisfactorily
  • Long-term stability priority (some applications)

Best applications for Voluma

  • Significant cheek volume restoration
  • Premium clinic experiences
  • Brand familiarity matters to patient
  • Patients with previous Voluma experience

When Korean alternatives suffice

Korean filler is appropriate for

  • Subtle enhancement (most patients)
  • Lip filler (Korean technique excels)
  • Tear trough (specific products preferred)
  • Nasolabial folds (multiple Korean options)
  • Budget-conscious treatment
  • Most aesthetic applications

The 80/20 rule

Korean alternatives deliver 80–90% of imported performance at 50% of cost. For most patients, the cost-benefit favors Korean alternatives. Imported is justified for specific applications where the 10–20% difference matters significantly.

The injection technique matters most

Same filler, different results

Injection technique often matters more than brand choice:

  • Korean injector with Yvoire vs Western with Voluma
  • Cannula vs needle technique
  • Depth of placement
  • Distribution pattern
  • Experience-based judgment

Choose injector quality first

  • Documented case volume
  • Conservative aesthetic philosophy
  • Photographic before/after evidence
  • Then brand selection

The Korean clinic stocking practice

Premium clinics

  • Stock both Korean and imported brands
  • Patient choice presented
  • Clear pricing for each option
  • Recommendations based on specific case

Standard clinics

  • Mainly Korean brands
  • Some imported available on request
  • Mid-tier pricing
  • Quality results across options

Budget clinics

  • Korean brands primarily
  • Verify authentic product
  • Lower-tier pricing
  • Quality varies

Procedure details

Chin/jawline procedure with Volux

  1. Pre-procedure photography
  2. Topical numbing (30 minutes)
  3. Marking of injection points
  4. Multi-area injection with cannula
  5. Strategic placement on bone
  6. Symmetric distribution
  7. Massage for distribution
  8. Cooling and aftercare

Volume per session

  • Chin only: 1–2 mL Volux
  • Jawline: 2–4 mL Volux
  • Comprehensive lower face: 3–6 mL
  • Higher volumes often staged across sessions

Recovery

Immediate

  • Visible immediate result
  • Mild swelling for 24–48 hours
  • Possible minor bruising
  • Tenderness at injection sites

Days 1–7

  • Swelling resolving
  • Bruising fading
  • Final shape settling
  • Avoid pressure on treatment area

Weeks 2–4

  • Final result clear
  • Stable integration
  • Normal activities maintained

Long-term considerations

Volux duration

  • 12–18 months typical
  • Up to 24 months in some patients
  • Stable shape maintenance
  • Maintenance treatment needed

Voluma duration

  • 12–24 months typical
  • Established long-duration filler
  • Compatible with maintenance

Korean alternative duration

  • 12–18 months typical
  • Sometimes 3–6 months less than imports
  • Lower per-syringe cost compensates
  • Maintenance treatment cycle slightly more frequent

Side effects and risks

Similar across HA fillers:

  • Bruising at injection sites
  • Temporary swelling
  • Asymmetric initial result
  • Migration (very rare)
  • Allergic reactions (very rare)
  • Vascular events (technique-dependent, rare)

Reversibility

All HA fillers reversible with hyaluronidase:

  • Same enzyme works on all brands
  • Cost similar regardless of original filler
  • Critical safety feature
  • Korean clinics offer dissolution services

For international patients

Brand preference considerations

  • Home country familiarity
  • Specific clinical evidence
  • Maintenance compatibility
  • Insurance considerations
  • Brand prestige value

Cost-benefit analysis

  • For 1–2 syringe procedures: cost difference modest
  • For 4–6 syringe procedures: significant cost difference
  • Annual maintenance: cumulative cost matters
  • Combined with other procedures: budget allocation

The brand recognition factor

Why some patients prefer imported

  • Western marketing familiarity
  • "Premium brand" psychological value
  • Consistency with home country options
  • Established global track record
  • Peace of mind

Why Korean alternatives are competitive

  • MFDS regulatory approval
  • Significant clinical track record
  • Used in vast majority of Korean cases
  • Refined for Korean/Asian anatomy
  • Substantially lower cost

The Korean clinic recommendation

For most patients

Korean alternatives at trusted clinics deliver excellent results at substantially better cost. Choose imported when:

  • Specific Volux application benefit
  • Brand familiarity essential
  • Have used imported successfully previously
  • Budget allows comfortable choice

The hybrid approach

  • Imported Volux for chin/jawline
  • Korean alternatives for less critical areas
  • Combined treatment optimizes cost
  • Best of both approaches

The 2026 Korean filler market evolution

  • Continued Korean brand quality improvement
  • Innovation in Korean specialty formulations
  • Competition with imported brands intensifying
  • Newer Korean brands entering premium tier
  • Cost advantage maintained

How to discuss with your surgeon

  • Ask about specific recommendations for your case
  • Inquire about both options
  • Understand the specific differences
  • Consider total cost across syringes needed
  • Make informed decision

Honest framing

Imported Allergan Volux and Voluma represent legitimate premium choices for specific applications, particularly chin/jawline definition where Volux\'s unique cohesivity justifies cost. For most filler applications, Korean alternatives deliver comparable results at half the cost. The decision should be application-specific rather than blanket preference. For Volux specifically, the chin/jawline applications represent best value proposition. For Voluma, Korean alternatives like Yvoire Volume offer comparable performance at significant cost savings. The injection technique matters more than brand for final result quality — choose Korean injectors with documented case volume regardless of brand preference. For comprehensive treatment, hybrid approach often optimizes cost: imported for specific high-value applications, Korean for general aesthetic enhancement. Budget allocation should reflect specific case priorities. For international patients, the Korean filler market offers exceptional value across both Korean and imported options at significantly lower cost than home country alternatives.

← 목록으로